In vivo CRISPR inactivation of Fospromotes prostate cancer progression by altering the associated AP-1 subunit Jun

Prostate cancer is a major global health concern with limited treatment options for advanced disease. Its heterogeneity challenges the identification of crucial driver genes implicated in disease progression. Activating protein-1 (AP-1) transcription factor is associated with cancer since the first...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncogene
Asıl Yazarlar: Riedel, Maria, Berthelsen, Martin F., Cai, Huiqiang, Haldrup, Jakob, Borre, Michael, Paludan, S⌀ren R., Hager, Henrik, Vendelbo, Mikkel H., Wagner, Erwin F., Bakiri, Latifa, Thomsen, Martin K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7610543/
https://ncbi.nlm.nih.gov/pubmed/33674748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-021-01724-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller